Cargando…

Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice

Obesity is a significant risk factor for ovarian cancer (OC) and associated with worse outcomes for this disease. We assessed the anti-tumorigenic effects of metformin in human OC cell lines and a genetically engineered mouse model of high grade serous OC under obese and lean conditions. Metformin p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jianjun, Wysham, Weiya Z., Zhong, Yan, Guo, Hui, Zhang, Lu, Malloy, Kim M., Dickens, Hallum K., Huh, Gene, Lee, Douglas, Makowski, Liza, Zhou, Chunxiao, Bae-Jump, Victoria L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762298/ https://www.ncbi.nlm.nih.gov/pubmed/29340030 http://dx.doi.org/10.18632/oncotarget.20754

Ejemplares similares

Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells
por: Zhou, Chunxiao, et al.
Publicado: (2013)

Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer
por: Xu, Guangxu, et al.
Publicado: (2023)

The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth
por: Roque, Dario R., et al.
Publicado: (2021)

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
por: Schuler, Kevin M, et al.
Publicado: (2015)

Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells
por: Kong, Weimin, et al.
Publicado: (2015)

Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice
por: Grace, Matthew R., et al.
Publicado: (2019)

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
por: Suri, Anuj, et al.
Publicado: (2016)

Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017)

Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women
por: Makhija, Nidhi, et al.
Publicado: (2023)

Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
por: Guo, Hui, et al.
Publicado: (2016)

JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*
por: Qiu, Haifeng, et al.
Publicado: (2015)

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
por: Wang, Jiandong, et al.
Publicado: (2014)

Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease
por: Melnyk, Stepan, et al.
Publicado: (2023)

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
por: Zhang, Lu, et al.
Publicado: (2016)

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
por: Yuan, Lingqin, et al.
Publicado: (2015)

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
por: Wysham, Weiya Z., et al.
Publicado: (2012)

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2021)

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm?
por: Ahmed, Maimuna F, et al.
Publicado: (2021)

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
por: Fan, Yali, et al.
Publicado: (2022)

Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
por: Mentoor, Ilze, et al.
Publicado: (2020)

Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome
por: Majumdar, Abha, et al.
Publicado: (2009)

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
por: Sun, Li, et al.
Publicado: (2017)

Obesity, metabolism and the microenvironment: Links to cancer
por: Sundaram, Sneha, et al.
Publicado: (2013)

Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
por: Xu, Guangxu, et al.
Publicado: (2021)

Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020)

Multiorgan Insulin Sensitivity in Lean and Obese Subjects
por: Conte, Caterina, et al.
Publicado: (2012)

Bromocriptine and insulin sensitivity in lean and obese subjects
por: Bahler, L, et al.
Publicado: (2016)

Hepatic microbiome in healthy lean and obese humans
por: Suppli, Malte Palm, et al.
Publicado: (2021)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
por: Huang, Yu, et al.
Publicado: (2023)

Metformin Does Not Inhibit Exercise-Induced Lipolysis in Adipose Tissue in Young Healthy Lean Men
por: Krauzová, Eva, et al.
Publicado: (2018)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

A core gut microbiome in obese and lean twins
por: Turnbaugh, Peter J., et al.
Publicado: (2008)

Leptin, adiponectin and serotonin levels in lean and obese dogs
por: Park, Hyung-Jin, et al.
Publicado: (2014)

Should We Build “Obese” or “Lean” Anaerobic Digesters?
por: Briones, Aurelio, et al.
Publicado: (2014)

Distinct Hepatic Macrophage Populations in Lean and Obese Mice
por: Mayoral Monibas, Rafael, et al.
Publicado: (2016)

Subclinical Hypothyroidism in Danish Lean and Obese Children and Adolescents
por: Dahl, Maria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jtj232vb0l6qmek9o03baj2mh8